Paratek Pharmaceuticals, Inc. EBITDA Margin 2010-2023 | PRTK
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Paratek Pharmaceuticals, Inc. (PRTK) over the last 10 years. The current EBITDA margin for Paratek Pharmaceuticals, Inc. as of June 30, 2023 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2023-06-30 |
$0.18B |
$-0.04B |
-24.86% |
2023-03-31 |
$0.17B |
$-0.05B |
-28.74% |
2022-12-31 |
$0.16B |
$-0.05B |
-28.57% |
2022-09-30 |
$0.12B |
$-0.07B |
-59.83% |
2022-06-30 |
$0.11B |
$-0.07B |
-61.26% |
2022-03-31 |
$0.14B |
$-0.04B |
-29.71% |
2021-12-31 |
$0.13B |
$-0.04B |
-31.78% |
2021-09-30 |
$0.11B |
$-0.03B |
-27.43% |
2021-06-30 |
$0.10B |
$-0.03B |
-32.04% |
2021-03-31 |
$0.06B |
$-0.07B |
-118.18% |
2020-12-31 |
$0.05B |
$-0.08B |
-159.57% |
2020-09-30 |
$0.04B |
$-0.08B |
-202.50% |
2020-06-30 |
$0.03B |
$-0.09B |
-313.33% |
2020-03-31 |
$0.02B |
$-0.11B |
-465.22% |
2019-12-31 |
$0.02B |
$-0.12B |
-688.24% |
2019-09-30 |
$0.03B |
$-0.12B |
-460.00% |
2019-06-30 |
$0.02B |
$-0.12B |
-552.38% |
2019-03-31 |
$0.02B |
$-0.11B |
-594.74% |
2018-12-31 |
$0.02B |
$-0.11B |
-623.53% |
2018-09-30 |
$0.01B |
$-0.11B |
-2120.00% |
2018-06-30 |
$0.01B |
$-0.10B |
-1920.00% |
2018-03-31 |
$0.01B |
$-0.08B |
-646.15% |
2017-12-31 |
$0.01B |
$-0.08B |
-638.46% |
2014-12-31 |
$0.00B |
$-0.01B |
-200.00% |
2014-06-30 |
$0.01B |
$0.00B |
66.67% |
2014-03-31 |
$0.01B |
$0.00B |
50.00% |
2013-12-31 |
$0.00B |
$-0.01B |
inf% |
2013-09-30 |
$-0.01B |
$-0.02B |
328.57% |
2013-06-30 |
$0.00B |
$-0.01B |
-466.67% |
2013-03-31 |
$0.00B |
$-0.02B |
-533.33% |
2012-09-30 |
$0.02B |
$0.00B |
4.35% |
2012-06-30 |
$0.01B |
$-0.01B |
-64.29% |
2011-12-31 |
$0.02B |
$-0.00B |
-10.00% |
2011-09-30 |
$0.01B |
$-0.01B |
-100.00% |
2011-06-30 |
$0.01B |
$-0.01B |
-58.33% |
2011-03-31 |
$0.01B |
$-0.01B |
-58.33% |
2010-12-31 |
$0.01B |
$-0.01B |
-58.33% |
2010-09-30 |
$0.01B |
$-0.01B |
-58.33% |
2010-06-30 |
$0.01B |
$-0.01B |
-72.73% |